Details for 2023154663

Up to date per 11.04.2026

Actions

Title / Product Name

VANZACAFTOR ZUR VERWENDUNG BEI DER BEHANDLUNG VON MUKOVISZIDOSE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2023154663

EP Publication Number

4218754

E-Number

1900826

Language

PCT Number

Publication Date

02.08.2023 A

25.03.2026 B1

Registration Date

25.03.2026

AT Publication Date

15.04.2026

Application Date

13.11.2019

Registration Number

Priorities

14.11.2018

201862767202 P

IPC

A61K 31/404 20060101AFI20230711BHEP

Maximum Duration of Protection

13.11.2039

Owner

Vertex Pharmaceuticals Incorporated50 Northern Avenue Boston, MA 02210US

Representative

No representatives present

Inventor

ALTSHULER, David M. Boston, 02210US

ANDERSON, Corey Don Boston, 02210US

CHEN, Weichao George Boston, 02210US

CLEMENS, Jeremy J Boston, 02210US

CLEVELAND, Thomas Boston, 02210US

COON, Timothy Richard Boston, 02210US

FRIEMAN, Bryan Boston, 02210US

GROOTENHUIS, Peter deceasedUS

HADIDA RUAH, Sara Sabina Boston, 02210US

HARE, Brian J. Boston, 02210US

KEWALRAMANI, Reshma Boston, 02210US

MCCARTNEY, Jason Boston, 02210US

MILLER, Mark Thomas Boston, 02210US

PARASELLI, Prasuna Boston, 02210US

PIERRE, Fabrice Boston, 02210US

ROBERTSON, Sarah M. Boston, 02210US

SOSNAY, Patrick R. Boston, 02210US

SWIFT, Sara E. Boston, 02210US

ZHOU, Jinglan Boston, 02210US

BOREK, Bartlomiej Boston, 02210US

VAN GOOR, Fredrick Boston, 02210US

YOUNG, Tim Boston, 02210US

Information about Fees